Product Information
CLOZAPINE 50 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.5418 per EA under NDC 00904740661. Its NADAC has been published 128 times since Apr 24, 2024.
FDA first approved this application on Nov 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904740661
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA206433FDA Approved
11/29/2016
TE Code
AB
On Market Since
11/29/2016
Pharmacological Classes
Price Statistics
The NADAC for CLOZAPINE 50 MG TABLET has been published 128 times since Apr 24, 2024, and over the history we have for it it has risen 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5418 per EA |
|---|---|
| All-time high | $0.5596 (Apr 16, 2025) |
| All-time low | $0.4172 (Jul 17, 2024) |
| 52-week high | $0.5461 |
| 52-week low | $0.4791 |
| Median price | $0.5153 |
| Average price | $0.5080 |
| Largest weekly change | +24.4% (Aug 21, 2024) |
| Weeks tracked | 128 |
| Tracking since | Apr 24, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOZAPINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOZAPINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZAPINE 50 MG TABLET, manufactured by Major Pharmaceuticals, is $0.5418 per EA (NDC 00904740661), effective Sep 30, 2026.
How has the price of CLOZAPINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZAPINE 50 MG TABLET has risen 19.5%. It has been tracked across 128 weekly CMS publications since Apr 24, 2024.
What are the highest and lowest recorded NADAC prices for CLOZAPINE 50 MG TABLET?
Since Apr 24, 2024, the NADAC for CLOZAPINE 50 MG TABLET has ranged from a low of $0.4172 (Jul 17, 2024) to a high of $0.5596 (Apr 16, 2025), with a median of $0.5153 per EA.
Are there cheaper alternatives to CLOZAPINE 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOZAPINE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOZAPINE 50 MG TABLET?
CLOZAPINE 50 MG TABLET (NDC 00904740661) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.